Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.
Access advanced solid tumors specialists in Columbus at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced solid tumors treatment provided free
This is a first-in-human, multicenter, Phase 1/2, open-label study designed to evaluate the safety and tolerability of XTX301 as monotherapy in patients with advanced solid tumors.
Sponsor: Xilio Development, Inc.
Check if you qualify for this advanced solid tumors clinical trial in Columbus, OH
If you're searching for advanced solid tumors treatment options in Columbus, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbus research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.